The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease

[1]  V. Aboyans,et al.  HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi , 2021, Scientific Reports.

[2]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[3]  K. Rahimi,et al.  Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. , 2019, The Lancet. Global health.

[4]  J. Beckman,et al.  Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease , 2018, Circulation.

[5]  Chi-Hsiang Chung,et al.  Tuberculosis increases the risk of peripheral arterial disease: A nationwide population‐based study , 2017, Respirology.

[6]  Freya J. I. Fowkes,et al.  Peripheral artery disease: epidemiology and global perspectives , 2017, Nature Reviews Cardiology.

[7]  J. Spertus,et al.  Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries. , 2016, International angiology : a journal of the International Union of Angiology.

[8]  Liam Smeeth,et al.  The Malaria-High Blood Pressure Hypothesis , 2016, Circulation research.

[9]  B. Howard,et al.  The impact of birth weight on cardiovascular disease risk in the Women's Health Initiative. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  J. Budzyński,et al.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review , 2015, International Journal of Angiology.

[11]  T. Bousema,et al.  Is asymptomatic malaria really asymptomatic? Hematological, vascular and inflammatory effects of asymptomatic malaria parasitemia. , 2015, The Journal of infection.

[12]  T. Sterling,et al.  Tuberculosis and cardiovascular disease: linking the epidemics , 2015, Tropical Diseases, Travel Medicine and Vaccines.

[13]  T. Oni,et al.  Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition , 2015, International health.

[14]  P. Reiss,et al.  Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Igor Rudan,et al.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.

[16]  Q. Fang,et al.  HIV infection: an independent risk factor of peripheral arterial disease. , 2010, Journal of acquired immune deficiency syndromes.

[17]  A. Algra,et al.  Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. , 2001, Atherosclerosis.